BDBM2674 US8507510, 3.0

SMILES CCC(CO)Sc1nc(Nc2ccc(cc2)S(C)(=N)=O)ncc1Br

InChI Key InChIKey=GLHAYKFNIDJXMB-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 2674   

TargetCyclin-dependent kinase 2(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM2674(US8507510, 3.0)
Affinity DataIC50: 16nMAssay Description:Kinase assay using either CDK1, CDK2 or VEGFR-2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2013
Entry Details
US Patent

TargetCyclin-dependent kinase 1(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM2674(US8507510, 3.0)
Affinity DataIC50: 49nMAssay Description:Kinase assay using either CDK1, CDK2 or VEGFR-2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2013
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM2674(US8507510, 3.0)
Affinity DataIC50: 170nMAssay Description:Kinase assay using either CDK1, CDK2 or VEGFR-2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2013
Entry Details
US Patent